There is ample evidence from adoptive transfer experiments that the actual number of antigenreactive cells present at the site of a delayed hypersensitivity skin reaction is very small [1] . The large majority of cells infiltrating the lesion appear to be immunologically uncommitted, and have been attracted to the site by the few antigenresponding cells or substances produced by these cells. It has been suggested that the initial reaction of antigen with a few specifically sensitized lymphocytes results in the production of chemical mediators which, through their biologic activity , are capable of recruiting host-inflammatory cells , activating them, and keeping them at the site of the reaction.
A number of in vitro models have been developed which permit isolation of cells potentially involved in the cell-mediated immune (CMI) reaction and study of their function and interactions. These methods involve culturing sensitized lymphocytes with specific antigens or nonspecific mitogens and assaying the culture medium from these cells for the presence of various biologic activities. A list of lymphocyte mediators is shown in Table 1 . These factors affect the behavior of macrophages , polymorphonuclear (PMN) leukocytes, lymphocytes, and other cell types. By virtue of their biologic effects, one can see how they may play a role in vivo in the expression of CMI reactions in the skin , in resistance to infection by intracellular facultative organisms, and inflammation.
While these substances exert marked biologic effects on cells in the microenvironment, they are produced in only minute quantities by activated lymphocytes. Few of the mediators have been purified sufficiently to learn about their structure and raise antibodies against them so that their Reprint requests to Dr. R. E. Rocklin detection might be simplified. We do not know how many chemically distinct mediators there are , nor how many are actually involved in vivo in CMI reactions. However, several lymphocyte mediators have been partially characterized by physicochemical techniques and shown to be distinct entities, having effects on different indicator cells . This paper will deal with a description of the known characteristics and function of soluble lymphocyte factors, their assay systems, possible in vivo effects , pharmacologic modulation, and clinical significance.
FACTORS AFFECTING MA CROPHAGES

Macrophage Migration Inhibitory Factor (MIF)
The first of the lymphocyte mediators to be described was MIF. Many years ago it was shown that cells from spleen fragments obtained from tuberculous guinea pigs would be inhibited in their migration if these cells were first exposed in vitro to old tuberculin antigen [2] . The migration of mononuclear cells from explants obtained from normal animals was not inhibited when exposed to the same antigen. Cells were shown to be directly or inherently antigen-sensitive and not reactive because of the influence of circulating antibody. The explant system was replaced by a more quantitative and reproducible method which utilized peritoneal exudate cells obtained from immune animals that have been placed in small glass capillary tubes [3] [4] [5] . Peritoneal exudate cells (PEC) consist primarily of macrophages (70-80 %) and some lymphocytes (10-20 %) . The capillary tubes are placed in chambers which are incubated at 37°C for 18 to 24 hr. During this period , the cells migrate out of the capillary tube onto the glass surface of the chamber. In the presence of a specific antigen, sensitized PEC do not migrate as far as cells that are not exposed to antigen. The areas of cell migration are measured by planimetry and the ratio of migration inhibition in the presence of antigen to that in the absence of antigen is calculated. In this system, MIF is produced by the lymphocytes present in the cell suspension and it acts upon the macrophages. The effects of MIF on macrophages are nonspecific , in that lymphocytes can be cultured separately from immune macrophages, stimulated with antigen or mitogen and shown to release MIF. This material will inhibit the migration of macrophages from nonimmune animals.
Human lymphocytes also produce MIF [6, 7] which inhibits the migration of human monocytes 372 or guinea-pig macrophages used as indicator cells. The production of antigen-induced MIF by human and animal lymphocytes is closely associated with the presence of in vivo cellular hypersensitivity to that antigen. Under some circumstances, however, lymphocytes release MIF in the absence of a specific immunologic reaction. For example, if lymphocytes have been activated in vitro by mitogens or other nonspecific stimulants, they produce MIF as well as other mediators. MIF production can be detected 4 to 6 hr after lymphocytes have been activated in vitro. The cells will continue to release MIF for as long as 4 days, provided that a stimulant is continued.
MIF is resistant to the effects of heating at 56°C for 30 min and is a nondialyzable macromolecule. Its activity is not diminished when the material is treated with RNase and DNase, but it is inactivated following enzymatic treatment with trypsin and chymotrypsin [5] . That MIF is actively synthesized by cells following stimulation was shown in experiments where puromycin was used. Pretreatment of lymphocytes with puromycin prevented MIF production by lymphocytes. In addition, puromycin has an effect on macrophages in MEDIATORS OF CELLULAR IMMUNITY 373 that they are no longer able to respond to preformed MIF. Actinomycin-D (an inhibitor of DNAdependent RNA synthesis) also prevents lymphocytes from elaborating MIF. Agents such as cortisone or prednisone do not prevent the lymphocyte from producing MIF in vitro in nontoxic doses, although they are effective in obliterating the delayed type hypersensitivity skin test [8, 9] . Their effect is probably on the macrophage response to preformed MIF.
The properties of guinea-pig and human MIF are compared in Table II . Guinea-pig MIF has the properties of an acidic glycoprotein (35,000-55,000 daltons) while human MIF has the properties of a smaller protein (25,000 daltons) .
Little is known about the interaction of MIF with its receptor on the macrophage membrane. Early studies showed that macrophages incubated with trypsin initially failed to respond to MIF but after 24 hr regained their ability to do so [5] . This suggested that trypsin either altered the macrophage membrane or removed receptors for MIF. If macrophages are preincubated with MIF -containing supernatants, then MIF activity is removed, presumably by absorption to the cells [10] . This does not occur if the macrophages are pretreated with trypsin before being exposed to MIF. More recently, it was shown that a-L-fucose blocked MIF activity on macrophages [11] . Furthermore, macrophages incubated with a-L-fucosidase (which cleaves terminal fucose from the oligosaccharide) are no longer able to respond to MIF. These observations suggest that a-L-fucose is an important component of the MIF receptor on the macrophage membrane.
Recent evidence suggests that an active serine esterase associated with the macrophage membrane regulates this cell 's response to MIF. Both diisopropyl fluorophosphate (DFP) and several plasma esterase inhibitors are able to enhance the effect of MIF on macrophages [12, 13] .
Macrophage Activation Factor
Macrophages obtained from animab; made immune by infection exhibit enhanced cunction when these cells are cultured in vitro. They appear more spread out on glass, are more adhen:nt, more phagocytic, and show enhanced bacteri"idal activity even against organisms that are antigenically unrelated to those which have infected the host [14, 151. The in vivo state of activation of macrophages obtained from animals undergoing an ac- tive infection can be simulated in vitro by exposing macrophages or monocytes from normal individuals to lymphocyte mediators . It was first shown in the guinea pig that normal macrophages could be "activated" after 72 hr of incubation with a macromolecule similar to, if not identical with, that of MIF [16, 17] . The changes that were observed included increased adherence to their culture vessel, increased rates of phagocytosis , increased oxidation of glucose through the hexose monophosphate shunt pathway, increased ruffled membrane activity, and increased motility. In man, human monocytes can be isolated from the blood and cultivated in vitro in monolayers [18] . These cells can then be exposed to the activating principle (MIF); and one can determine, over a period of several days , whether or not these blood monocytes have become activated. Monolayers of normal macrophages can be activated by MIF to kill hepatoma cell lines in vitro [19] . Such activated macrophages did not kill either syngeneic fibroblasts or kidney cells.
It is of interest that the activation of macrophages or monocytes takes several days to occur while the inhibition of migration of macrophages may be observed within 24 hr. Just how the inhibition of macrophage migration is related to the later activation of these cells is not known. It has been observed that the inhibition of macrophage migration is a reversible process; cells initially inhibited in the first 24 hr may begin to migrate again and will actually travel at a faster rate than macrophages in control chambers. It may be that the initial effect of MIF on macrophage function is to change the surface properties of that cell so that it becomes more adherent. This is observed in one assay as inhibition of migration. Later, other metabolic changes occur in the cell so that it becomes activated and, in fact, its function in g~neral is enhanced. The effects of lymphocyte medIators on macrophage function are listed in Table III . 
Macrophage (Monocyte) Chemotactic Factor
Antigen-activated or mitogen-activated lymphocytes elaborate a chemotactic substance which selectively attracts macrophages or monocytes [20] . The chemotactic assay is carried out using a chamber which consists of an upper and lower c.ompartn:ent that is separated by a micropore fIlter havmg a certain pore size. The suspension of macrophages or monocytes is placed in the upper co~partment, while the lower compartment contams the ch.emotactic material. Usually, one places culture flUId from unstimulated lymphocytes or antigen-stimulated or mitogen-stimulated lymphocytes into the lower compartment to serve as a chemotactic stimulus. The chambers are incubated at 37°C for varying times, and the number of cells which migrate through the micropore filter from the top side to the bottom surface, ar~ counted. The chemotactic activity of the culture fluid is assessed morphologically by determining the number of cells that have migrated through the micropore filter.
A variation of this assay is one in which the indicator macrophages are labeled with a radioactive substance such as 51Cr and two filters instead of one are used [21] . After the appropriate incubation time, the amount of radioactivity present in the lower filter is determined. This latter modification ~orrelates very well with the morphologic countmg of cells and is perhaps more objective.
The production of macrophage chemotactic factor, li~e other mediators, is antigen specific. The factor IS heat stable after incubation at 56°C for 30 min. Its molecular weight in the guinea-pig is 35,000 to 55,000 daltons, and in man appears to be between. 12,000 and 25,000 daltons [22, 23] . On acryiamide gel electrophoresis, the chemotactic activity can be found to migrate in that part of the g~l ~ssociated with albumin. Its buoyant density is SImIlar to that of pure protein, and it is inactivated by treatment with chymotrypsin, but not neuraminidase [24] .
The process of chemotaxis or directed migration takes place when the cells are presented with a gradient of the chemotactic material. If the chemotactic material is placed in the upper chamber as well as being in the lower chamber, the net result is a loss of directed movement of the cells towards the lower chamber. Furthermore, it has been shown that MIF does not interfere with the activity of chemotactic factor [22 J. If MIF is placed in the upper chamber, the net result is an increased movement of the cells towards the lower compartment. When chemotactic factor is placed in the upper chamber with the cells and MIF in the lower cham ber, the net result is a loss of directed movement towards the lower compartment.
FACTORS WHICH AFFECT PMN LEUKOCYTES
Leukocyte Inhibitory Factor (LIF)
. T~e system of PMN leukocyte migration inhibition m man appears to be analogous to that seen in Sept. 1976 the macrophage system. PMN leukocytes are inhibited in their migration by a soluble material termed LIF [25] [26] [27] [28] . The effect of LIF appears to be solely on PMN leukocyte migration and not upon the migration of macrophages. LIF is produced by sensitized lymphocytes following incubation with specific antigen as well as after stimulation by concanavalin A. LIF is assayed using human buffy coat cells, as indicated, or by purifying PMN leukocytes from the blood and placing them either in capillary tubes as in the MIF system or in agar. Cell migration is measured at 18 to 24 hr, the relative areas of migration are determined and the amount of inhibition of cell migration calculated.
Human LIF is nondialyzable, heat stable at 56°C for 30 min, and has an approximate molecular weight on gel filtration of 68,000 daltons [29] . Electrophoretically, it has a similar charge to that of albumin and has a buoyant density comparable to that of protein. It is inactivated by enzymatic treatment with chymotrypsin but is resistant to neuraminidase. LIF appears to be a protease because of its sensitivity to the alkylating effects of DFP. In contrast, human MIF is resistant to DFP . It is not known at present how LIF affects PMN leukocyte function in other respects.
Chemotactic Factors for Neutrophils, Basophils, and Eosinophils
Sensitized lymphocytes elaborate chemotactic factors for all three types of PMN leukocytes [22, [30] [31] [32] . There appear to be two factors which affect the directed movement of eosinophils [30, 31 J. One of these factors requires the interaction of the mediator with specific antigen-antibody complexes in order to generate the activity, whereas the other factor is active in the absence of antigen-antibody complexes. The chemotactic factors have similar molecular weights ranging from 24,000 to 55,000 daltons. The chemotactic factor for neutrophils has been separated from that for macrophages [22] . The latter two factors have been found to migrate in different parts of a gel during electrophoresis. It is not clear at the present time, however, whether these factors are all distinct materials or the same substance having chemotactic activity for multiple cell types. These chemotactic factors may playa role in various chronic inflammatory conditions or in certain types of delayed hypersensitivity reactions such as the Jones Mote (cutaneous basophil hypersensitivity) reaction [32] .
MEDIATORS AFFECTI NG LYMPHOCYTES
Lymphocy te Mitogenic Factor (LMF)
Sensitized lymphocytes, stimulated by specific antigen, release into the culture fluid a substance that has mitogenic activity for nonsensitized lymphocytes [33, 34] . This material induces normal lymphocytes to undergo blast transformation and incorporate increased amounts of tritiated thymidine into cellular DNA. The culture fluids are incubated with nonsensitive lymphocytes for ap-
the incorporation of tritiated thymidine into cellular DNA. An increase in cell division is usually found in the cultures that have been incubated with culture fluids obtained from antigenstimulated lymphocytes rather than with culture fluids from unstimulated lymphocytes.
LMF in the guinea-pig is a nondialyzable macromolecule and is heat stable at 56°C for 30 min . It is resistant to treatment with RN ase and DN ase as well as to treatment with proteolytic enzymes such as trypsin [35, 36] . It has a molecular weight of approximately 20,000 to 30,000 daltons. While LMF is produced within the first 6 hr of culture, it is not clear whether DNA synthesis is required for the cells to be able to generate the material.
Mitogenic factors capable of activating or recruiting nonsensitive lymphocytes could furnish a mechanism for expanding a cellular reaction and producing greater amounts of mediators. The exact role of LMF in the proliferative response is not clear. It may be that the first stage of proliferation is initiated after activated lymphocytes have released LMF. The second stage would be the nonspecific activation of other lymphocytes by the material. Alternatively, some sensitized lymphocytes may proliferate directly in the absence of LMF if they have been stimulated by an antigen to which they are sensitized.
Factors That Affect Antiaody Production
Lymphocytes from several species, following stimulation by a specific antigen , have been shown to produce soluble factors which modulate antibody production [37] [38] [39] . In the mouse, a material has been described which triggers B-lymphocytes to make antibody of the 19S class to sheep red blood cells . In addition, factors have been reported which also increase IgG and IgE antibody production. In man, a material has been described which induces B-lymphocytes to proliferate, lose their C3 receptors, increase their protein synthesis , and induce production of IgG antibody to specific antigens [40) . On the other hand, soluble factors have been reported in some species which suppress antibody production.
The factors that modulate antibody production have not been well characterized, and it is not known whether they are the same factor acting at different concentrations or several d~stinct materials . The enhancing factor appears to be a nondialyzable, heat-stable macromolecule. The antibody-suppressing factor appears also to be a nondialyzable material with a molecular weight of 25,000 to 55,000 daltons. This material may provide a mechanism by which thymic-derived T -lymphocytes and bone marrow-derived B-lymphocytes cooperate in the production of antibody to certain antigens. It would appear that the B-cell, following stimulation by antigen, is not triggered directly to synthesize antibody until it has received a second signal from the T-Iymphocyte which may be a soluble factor.
Transfer Factor (TF)
The ability to transfer delayed hypersensitivity in man can be accomplished by means of a dialyzable material obtained from sensitized individuals [41] [42] [43] . Sensitized lymphocytes contain a small -molecular-weight substance called TF which is released either by disrupting the cells or by stimulating them with a specific antigen. This material has the capability of preparing nonsensitive lymphocytes which are exposed to it to respond to specific antigen by undergoing increased DNA synthesis and mediator production.
TF has a molecular weight of less than 4,000 daltons, is resistant to treatment by DNase and RNase, but is orscinol positive. The mechanism by which TF is able to prepare nonsensitized lymphocytes to respond to specific antigen is unknown. There is some indication that the material may be a single-stranded polynucleotide which is either informational or may provide some part of a receptor for antigen.
MEDIATORS AFFECTING OTHER CELL TYPES
Cytotoxic Factors and Growth Inhibitory Factors
Immune lymphocytes may bring about the cytolysis of certain susceptible target cells in two ways. One way involves the lymphocyte attaching directly to the target cell and by a mechanism which is not known, bringing about its lysis . This is referred to as direct lymphocyte-mediated cytolysis [44] . A second mechanism involves the release of a soluble factor called lymphotoxin (LT), which, in the absence of the lymphocyte, may also bring about the lysis of certain target cells [45] . This phenomenon was first described in' the rat where lymph node lymphocytes obtained from sensitized animals produced a soluble factor which killed normal rat embryo fibroblasts. Subsequently, lymphotoxic substances have been described in other species including man [46, 47] . Guinea-pig L T is heat labile, has an estimated molecular weight of 35,000 to 55,000 daltons, migrates electrophoretically with albumin, has a buoyant density similar to t.hat. of protein, and is inact.ivated by chymotrypsin but is resist.ant to neuraminidase [24] . Human LT is heat stable, has a molecular weight of 80,000 to 90,000 daltons, migrates past albumin on electrophoresis, and also has a buoyant density similar to that of pure protein [48, 49] . A mechanism by which L T acts on susceptible target cells has been postulated [50] . The lymphocyte, having been activated by intimate contact with target cell membranes, is induced into synthesis of the mediator. Following its production, LT binds to the target cell membrane where it affects target cell lysis. Target cell membrane disruption or physical dislodgement promotes the lymphocyte's release from the target cell and subsequent cessaVol. 67, No.3 tion of LT secretion. This mechanism would inhibit an indiscriminate destruction by lymphocytes which produce the factor and prevents nonspecific cell damage to the host. The significance of in vivo production of LT is unknown. It might be related to tumor surveillance, i.e., the destruction of neoplastic cells, but how it relates to other delayed hypersensitivity reactions is not clear. Some activities have been described which, rather than causing the lysis of target cells, inhibit their growth pattern [51, 52] . Such materials have been referred to as proliferation inhibition factor and cloning inhibition factor. These materials have their effect mainly on certain target cells such as human HeLa cells. It has recently been shown that all three of these activities may be present in the same culture fluid [53] . When present in high concentration, the effect of LT is seen. At lower levels, a permanent growth inhibition is observed, and at still lower concentrations of mediator only a temporary inhibition of cell growth is noted. It is still not apparent whether the effects of lysis and growth inhibition are the result of three separate macromolecules or one molecule which can exert diverse effects on different cells, depending upon its concentration in the medium.
Interferon (IF)
Many cell types can be induced by viruses to prod uce IF. Lymphocytes may also produce IF -like materials when stimulated by viral or nonviral inducers. IF -like activity can be detected in the culture fluid of both antigen-stimulated and mitogen-stimulated lymphocytes [54, 55] .
The antigen-induced or mitogen -induced IF and the viral-induced IF share similar characteristics [56] . They are stable at pH 4.0-10.0, stable for 24 hr at 4 DC, nonsedimentable at 100,000 x g for 2 hr, resistant to DNase and RNase, but destroyed by trypsin . Their effect is specific for cells of human origin. IF production following or during a specific immunologic reaction is potentially important to the host. Persons who are unable to mount an adequate cellular immune response are plagued by viral infections and whether or not their lymphocytes are able to release IF following stimulation by certain antigens may help determine the level of their resistance to this type of infection .
Osteoclast-Activating Factor (OAF)
There are several substances capable of causing the resorption of bone. These include parathyroid hormone, prostaglandin E 2 , vitamin D metabolites, and other sterols . Recently, another mediator of bone resorption has been identified that may be of importance in causing the hypercalcemia seen in neoplastic disease or in the pathogenesis of bone resorption in dental caries. This material is produced by lymphocytes in vitro following stimulation by specific antigen or mitogen and is capable of forming osteoclasts in bone and activating these cells [57] . The technique for measuring bone Sept. 1976 resorption in organ culture consists of labeling shafts of radius or ulna from 19-day-old rat fetuses with 45Ca. The culture fluids from lymphocytes are incubated with the organ cultures for 4 to 6 days. The ratio of 4 5 Ca released into the medium from control and treated bone cultures is used as a measure of bone resorption.
Procoagulant Factor Activity (Tissue Factor)
Antigen-stimulated or mitogen-stimulated lymphocytes produce a procoagulant material which when incubated with factor VIII-deficient plasma is able to correct the prolonged clotting time [58] . This material is antigenic ally distinct from factor VIII and has been identified as being tissue factor. It is very labile and, thus far , has not been well characterized. The pathophysiologic importance of lymphocyte tissue factor has yet to be determined, but it is interesting to consider the various disease entities characterized both by lymphocytic infiltration and pathologic thrombosis such as the rejection of a transplanted kidney.
Colony-Stimulating Activity (CSA)
The differentiation of marrow cells into granulocytes and mononuclear cells in vitro can be accomplished by the addition of a colony-stimulating factor [59] . While blood monocytes and tissue macrophages appear to be a major source of this material, recent evidence suggests that lymphocytes may also actively produce CSA during an immunologic reaction. Mitogen-activated lymphocytes from thymus and spleen elaborate CSA after 4 days in culture . CSA is described as being a heat-stable glycoprotein with a molecular weight of approximately 40,000 to 60,000 daltons.
IN VI VO SIG NIFI CAN CE OF MEDIATORS
Skin Reactive Factor
That products of activated lymphocytes may playa role in the expression of delayed hypersensitivity was shown when lymphocyte mediat ors were injected into the skin of normal animals [60] . A partially purified preparation of lymphocyte mediators derived from antigen-stimulated cells caused the accelerated development of a delayedtype hypersensitivity reaction in the skin of normal guinea pigs. The reaction was characterized by the development of erythema and induration at 3 to 5 hr, which reached a peak by 8 to 12 hr, and disappeared by 30 hr. Histologically, the lesion simulated that of a delayed-type hypersensitivity reaction with the infiltrate comprised primarily of mononuclear cells . The factor or factors responsible for this reaction could be destroyed by trypsin and papain but not by DNase or RNase [61] . Drugs such as puromycin, chlorphensin, and actinomycin prevented its production. Cortisone had no effect on its production in vitro by lymphocytes , although it could prevent the expression of this reaction in vivo. Since preparations used to elicit MEDIATORS OF CELLULAR IMMUNITY 377 this response contain several mediators including MIF, chemotactic factor, LT and mitogenic factor, it is not clear at present whether one or a combination of these is responsible for the development of the skin reaction. Some preparations of skin-reactive factor also possess vasoactive properties. When injected into the skin, this material will induce the extravasation of Evan's blue dye between 20 min and 4 hr. The increased permeability induced by skin-reactive factor is not blocked by inhibitors of histamine or 5-hydroxytryptamine but is affected by inhibitors of the kinin system.
Mac-rophage Disappearance R eaction
If one injects mineral oil intra peritoneally into normal guinea-pigs , there develops over the next few days a peritoneal exudate cell population characterized primarily by macrophages. If specific antigen is injected intra peritoneally along with the oil in an appropriately sensitized guinea pig, the exudate which forms contains considerably fewer macrophages . This phenomenon has been termed the macrophage disappearance reaction and is associated with a delayed hypersensitivity state [62, 63 ] . Culture fluids derived from antigenstimulated lymphocytes can substitute for intact cells in the elicitation of this phenomenon in vivo . This reaction is mediated by a factor similar to if not identical with MIF. The mechanism to explain this reaction is unknown but may involve the fact that the macrophages have become sticky, adhere to the peritoneum, and are absent from the exudate.
Mediator Activity Found in S erum
Since the usual means for eliciting mediator production is by culturing lymphocytes in vitro, it is interesting that MIF and IF activities can be detected in the serum of animals undergoing an immunologic reaction [64] . Serum collected from animals immunized with bacillus CalmetteGuerin and then desensitized by administering a large dose of old tuberculin antigen intravenously was found to contain these activities. When sera from desensitized animals were filtered over a Sephadex column, both activities were found in the same fraction (molecular weight 45 ,000 daltons).
Effect of Mediators on Lymph Node Architecture
If the efferent lymph from animals undergoing an immunologic reaction is collected, mediatorlike activity may be detected in this fluid [65] . MIF -like and mitogenic activity is found in efferent lymph several days after antigen has been injected into the draining lymph nodes. In addition, other changes occur at this time, including increased vascular permeability, increased flow rate of lymph, and increased output of lymphocytes in the efferent lymph. When preformed mediators are injected into the afferent lymphatics, similar changes to those that develop in response to antigenic challenge may be observed [66] . These changes include increased numbers of cells in the efferent lymph as well as paracortical distention and germinal center enlargement. It is thought that the mediators may in some way cause cellular retention by plugging the efferent vessels, thus regulating the rate of efflux of these cells .
CELL TYPES PRODUCING MEDIATORS
Delayed hypersensitivity reactions are generally assumed to be mediated by thymus-dependent T -lymphocytes. It has further been assumed that antigen-induced production of lymphocyte mediators would be the sole function of T -lymphocytes. The recent availability of techniques to separate Tand B-lymphocytes into purified subpopulations has permitted an evaluation of which cell types produce these substances. Various studies indicate that both cell types are capable of producing some mediators. For example, both T -cells and B -cells are capable of producing MIF, chemotactic factor for macrophages, LIF, and IF [67] [68] [69] [70] . It appears, however, that lymphocyte-mitogenic factor and colony-stimulating factor are produced only by T -cells. Several of the lymphocyte mediators from both B-and T -cells have similar chromatographic patterns. Since B-cells apparently produce the same mediators as T -cells, a reinterpretation of the role of the B-cell in cellular immunity is needed.
PHARMACOLOGIC MODULATION OF MEDIATOR
PRODUCTIO N Cyclic 3'-5' -adenosine monophosphate (cAMP) plays an important role as a "second messenger" in the regulation of intracellular metabolism . In most normal secretory cells an increased level of cAMP results in increased production of cell products. In contrast, the immune system is affected differently by cyclic nucleotides. The antigen-induced release of histamine from basophils is abrogated by agents known to raise intracellular levels of cAMP. It has also been shown that certain immunologic reactions, such as lymphocyte-mediated cytotoxicity and the inhibition of macrophage migration by MIF, are also abrogated by agents which raise cAMP levels. Drugs such as isoproterenol, epinephrine, and prostaglandin E 1, which raise cAMP levels by stimulating adenylate cyclase, and theophylline, which retards its breakdown, interfere with the MIF-induced inhibition of guinea-pig macrophages [71, 72] . This effect appears to be on the macrophage response to MIF and not due to an inactivation of MIF by the drug. The dibutyryl derivative of cAMP is also effective in blocking MIF activity on macrophages. There is a suggestion that some drugs that elevate levels of cAMP also depress the lymphocyte production of MIF.
The vasoactive amine, histamine, also appears Vol. 67, No.3 to play a role in modulating the lymphocyte response to antigen [73] . There is preliminary evidence to suggest that histamine affects the lymphocyte production of MIF, but it does not appear to affect the macrophage response to preformed MIF: The effects of histamine on the lymphocyte production of MIF can be blocked by certain types of antihistamines (H 2)' but not by others (H 1)' Whether the inhibitory effect on MIF production by histamine is via its ability to raise cAMP levels or by the activation of certain suppressor lymphocytes which may subsequently suppress the MIFproducing cells is not known at present.
CLINICAL SIGNIFICANCE
The production of soluble mediators by lymphocytes from normal subjects generally correlates with the in vivo state of cellular immunity in that donor. These substances are not usually produced by antigens which fail to elicit a positive delayed skin test. Lymphocytes from some patients with depressed cellular immunity and cutaneous anergy also do not produce these mediators in response to antigenic stimulation [74] . For example, lymphocytes from some anergic patients with the DiGeorge syndrome, sarcoidosis, chronic mucocutaneous candidiasis, Wiskott-Aldrich syndrome, Hodgkin's disease, and rheumatoid arthritis do not produce the mediator MIF. In some cases, however, the proliferative response to antigens and mitogens may be normal, although MIF production is depressed. The cutaneous anergy in these patients may be due to a lack of mediator production (MIF) by their lymphocytes. In other anergic patients, MIF production and proliferative responses are normal, perhaps indicating intact lymphocyte function. Abnormalities in macrophage function or the inflammatory response might explain the anergy observed in these latter patients.
The MIF assay has also been used for the detection of sensitized lymphocytes in patients with certain diseases whose pathogenesis may involve an immune mechanism. Lymphocytes from patients with glomerulonephritis, thyroiditis , pernicious anemia, multiple sclerosis, and the Guillain-Barre syndrome produce MIF in response to various tissue antigens. This assay has also been used to detect sensitivity to drugs and tumor antigens.
